Edition:
United States

Marinus Pharmaceuticals Inc (MRNS.O)

MRNS.O on Consolidated Issue listed on NASDAQ Global Market

3.82USD
15 Feb 2019
Change (% chg)

$0.18 (+4.95%)
Prev Close
$3.64
Open
$3.65
Day's High
$3.84
Day's Low
$3.60
Volume
451,918
Avg. Vol
1,085,427
52-wk High
$10.54
52-wk Low
$2.36

Chart for

About

Marinus Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company. The Company focuses on developing and commercializing therapeutics to treat epilepsy and neuropsychiatric disorders. Its clinical-stage product candidate, ganaxolone, is a modulator being developed in various dose forms, including intravenous, oral... (more)

Overall

Beta: 3.26
Market Cap(Mil.): $200.65
Shares Outstanding(Mil.): 52.53
Dividend: --
Yield (%): --

Financials

  MRNS.O Industry Sector
P/E (TTM): -- 32.74 36.24
EPS (TTM): -0.86 -- --
ROI: -64.34 13.11 12.71
ROE: -64.49 14.08 13.70

Earnings vs. Estimates